{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:13:54Z","timestamp":1761844434033},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Doctoral Fund of Southwest University"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Protein Expression and Purification"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.pep.2014.09.001","type":"journal-article","created":{"date-parts":[[2014,9,10]],"date-time":"2014-09-10T15:32:20Z","timestamp":1410363140000},"page":"7-13","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Production and characterization of a fusion peptide derived from the rabies virus glycoprotein (RVG29)"],"prefix":"10.1016","volume":"104","author":[{"given":"Yu-Jiao","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping-Sen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Xia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Hong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Wei","family":"Gai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Wei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song-Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-Zhu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pep.2014.09.001_b0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/psc.983","article-title":"The role of peptides in blood\u2013brain barrier nanotechnology","volume":"14","author":"Teixido","year":"2008","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.pep.2014.09.001_b0010","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2217\/nnm.10.105","article-title":"Nonviral vectors for the delivery of small interfering RNAs to the CNS","volume":"5","author":"Posadas","year":"2010","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.pep.2014.09.001_b0015","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.addr.2011.10.007","article-title":"Nanotechnological advances for the delivery of CNS therapeutics","volume":"64","author":"Wong","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.pep.2014.09.001_b0020","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2174\/156652308786847996","article-title":"Applications of lentiviral vectors for biology and gene therapy of neurological disorders","volume":"8","author":"Lundberg","year":"2008","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.pep.2014.09.001_b0025","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nmeth.1514","article-title":"Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors","volume":"7","author":"Anliker","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.pep.2014.09.001_b0030","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1073\/pnas.91.8.3054","article-title":"Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo","volume":"91","author":"Chen","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pep.2014.09.001_b0035","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/43977","article-title":"Virus treatment questioned after gene therapy death","volume":"401","author":"Lehrman","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.pep.2014.09.001_b0040","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.biomaterials.2009.11.043","article-title":"The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy","volume":"31","author":"Kim","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.pep.2014.09.001_b0045","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1039\/B920753H","article-title":"Galactosylated cucurbituril-inclusion polyplex for hepatocyte-targeted gene delivery","volume":"46","author":"Kim","year":"2010","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.pep.2014.09.001_b0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2007.10.028","article-title":"Biodegradable polymers as non-viral carriers for plasmid DNA delivery","volume":"126","author":"Luten","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.pep.2014.09.001_b0055","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.biomaterials.2008.01.031","article-title":"An endosomolytic Tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection","volume":"29","author":"Lo","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.pep.2014.09.001_b0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.pep.2014.09.001_b0065","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/13550280590900427","article-title":"Rabies virus receptors","volume":"11","author":"Lafon","year":"2005","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.pep.2014.09.001_b0070","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1126\/science.7053569","article-title":"Is the acetylcholine receptor a rabies virus receptor?","volume":"215","author":"Lentz","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.pep.2014.09.001_b0075","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/mt.2010.27","article-title":"Targeted delivery of siRNA to macrophages for anti-inflammatory treatment","volume":"18","author":"Kim","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pep.2014.09.001_b0080","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1016\/j.biomaterials.2011.03.047","article-title":"A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA","volume":"32","author":"Hwang do","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.pep.2014.09.001_b0085","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.biomaterials.2009.02.051","article-title":"Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles","volume":"30","author":"Liu","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.pep.2014.09.001_b0090","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.pep.2014.09.001_b0095","doi-asserted-by":"crossref","first-page":"e11085","DOI":"10.1371\/journal.pone.0011085","article-title":"Liposome-siRNA-peptide complexes cross the blood\u2013brain barrier and significantly decrease PrP on neuronal cells and PrP in infected cell cultures","volume":"5","author":"Pulford","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pep.2014.09.001_b0100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2010.08.011","article-title":"RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain","volume":"155","author":"Son","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.pep.2014.09.001_b0105","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1016\/j.biomaterials.2011.12.017","article-title":"Target delivery of a gene into the brain using the RVG29-oligoarginine peptide","volume":"33","author":"Gong","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.pep.2014.09.001_b0110","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.addr.2011.11.010","article-title":"Modern methods for delivery of drugs across the blood\u2013brain barrier","volume":"64","author":"Chen","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.pep.2014.09.001_b0115","doi-asserted-by":"crossref","first-page":"23450","DOI":"10.1074\/jbc.M709387200","article-title":"Octaarginine- and octalysine-modified nanoparticles have different modes of endosomal escape","volume":"283","author":"El-Sayed","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pep.2014.09.001_b0120","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.1093\/nar\/gkp651","article-title":"Oligopeptide-mediated gene transfer into mouse corneal endothelial cells: expression, design optimization, uptake mechanism and nuclear localization","volume":"37","author":"Seow","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.pep.2014.09.001_b0125","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2010.11.004","article-title":"Endosomal escape pathways for delivery of biologicals","volume":"151","author":"Varkouhi","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.pep.2014.09.001_b0130","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.addr.2011.05.004","article-title":"Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery","volume":"63","author":"Yoo","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.pep.2014.09.001_b0135","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/nbt1340","article-title":"Renal clearance of quantum dots","volume":"25","author":"Choi","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.pep.2014.09.001_b0140","doi-asserted-by":"crossref","first-page":"425102","DOI":"10.1088\/0957-4484\/20\/42\/425102","article-title":"Positively charged and pH self-buffering quantum dots for efficient cellular uptake by charge mediation and monitoring cell membrane permeability","volume":"20","author":"Wang","year":"2009","journal-title":"Nanotechnology"},{"key":"10.1016\/j.pep.2014.09.001_b0145","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1023\/A:1025771421906","article-title":"Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation","volume":"20","author":"Chi","year":"2003","journal-title":"Pharm. Res."}],"container-title":["Protein Expression and Purification"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592814001910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592814001910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T18:58:18Z","timestamp":1538247498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046592814001910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":29,"alternative-id":["S1046592814001910"],"URL":"https:\/\/doi.org\/10.1016\/j.pep.2014.09.001","relation":{},"ISSN":["1046-5928"],"issn-type":[{"value":"1046-5928","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Production and characterization of a fusion peptide derived from the rabies virus glycoprotein (RVG29)","name":"articletitle","label":"Article Title"},{"value":"Protein Expression and Purification","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pep.2014.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}